FDA Approves First PCSK9 Inhibitor Pill for Cholesterol
The FDA approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for lowering cholesterol. Enlicitide is now approved as an adjunct to diet and exercise to reduce LDL cholesterol in…
The FDA approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for lowering cholesterol. Enlicitide is now approved as an adjunct to diet and exercise to reduce LDL cholesterol in…
Compare health Insurance & supplemental plans from trusted insurance providers. Get personalized quotes in minutes and speak with a licensed agent today.
Enter your ZIP code to see plans available in your area.
